These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12076995)

  • 1. The neuropathology of primary mood disorder.
    Harrison PJ
    Brain; 2002 Jul; 125(Pt 7):1428-49. PubMed ID: 12076995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional neuroanatomy of mood disorders.
    Soares JC; Mann JJ
    J Psychiatr Res; 1997; 31(4):393-432. PubMed ID: 9352470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
    Manji HK; Duman RS
    Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuropathology of schizophrenia. A critical review of the data and their interpretation.
    Harrison PJ
    Brain; 1999 Apr; 122 ( Pt 4)():593-624. PubMed ID: 10219775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.
    Cecil KM; DelBello MP; Sellars MC; Strakowski SM
    J Child Adolesc Psychopharmacol; 2003; 13(4):545-55. PubMed ID: 14977467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological changes of the brain in mood disorders.
    Wilczyńska K; Simonienko K; Konarzewska B; Szajda SD; Waszkiewicz N
    Psychiatr Pol; 2018 Oct; 52(5):797-805. PubMed ID: 30584814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can brain-imaging studies provide a 'mood stabilizer signature?'.
    Soares JC
    Mol Psychiatry; 2002; 7 Suppl 1():S64-70. PubMed ID: 11986997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell pathology in mood disorders.
    Rajkowska G
    Semin Clin Neuropsychiatry; 2002 Oct; 7(4):281-92. PubMed ID: 12382210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.
    Bachmann RF; Schloesser RJ; Gould TD; Manji HK
    Mol Neurobiol; 2005 Oct; 32(2):173-202. PubMed ID: 16215281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological brain changes in depression: can antidepressants reverse them?
    Miguel-Hidalgo JJ; Rajkowska G
    CNS Drugs; 2002; 16(6):361-72. PubMed ID: 12027783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomical MRI findings in mood and anxiety disorders.
    Brambilla P; Barale F; Caverzasi E; Soares JC
    Epidemiol Psichiatr Soc; 2002; 11(2):88-99. PubMed ID: 12212470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Affective disorders and dementia of the frontal lobe type. Hypothesis of a pathogenic relationship].
    Luauté JP; Favel P; Rémy C; Sanabria E; Bidault E
    Encephale; 1994; 20(1):27-36. PubMed ID: 8174508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology of the brain stem in psychiatric disorders.
    Hankoff LD; Peress NS
    Biol Psychiatry; 1981 Oct; 16(10):945-52. PubMed ID: 7306617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter alterations in bipolar disorder: potential for drug discovery and development.
    Marlinge E; Bellivier F; Houenou J
    Bipolar Disord; 2014 Mar; 16(2):97-112. PubMed ID: 24571279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder.
    Konarski JZ; McIntyre RS; Kennedy SH; Rafi-Tari S; Soczynska JK; Ketter TA
    Bipolar Disord; 2008 Feb; 10(1):1-37. PubMed ID: 18199239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis.
    Passamonti L; Cerasa A; Liguori M; Gioia MC; Valentino P; Nisticò R; Quattrone A; Fera F
    Brain; 2009 Dec; 132(Pt 12):3380-91. PubMed ID: 19420090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights help define the pathophysiology of bipolar affective disorder: neuroimaging and neuropathology findings.
    Haldane M; Frangou S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):943-60. PubMed ID: 15380855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study.
    Bielau H; Steiner J; Mawrin C; Trübner K; Brisch R; Meyer-Lotz G; Brodhun M; Dobrowolny H; Baumann B; Gos T; Bernstein HG; Bogerts B
    Ann N Y Acad Sci; 2007 Jan; 1096():157-69. PubMed ID: 17405927
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.